Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Swedish Orphan Biovitrum AB (publ)
  6. News
  7. All News
    SOBI   SE0000872095

SWEDISH ORPHAN BIOVITRUM AB (PUBL)

(SOBI)
  Report
Real-time Estimate Cboe Europe  -  08:08 2022-11-30 am EST
227.45 SEK   +3.81%
11/21Sobi - Bo Jesper Hansen proposed as new Chairman of the Board of Swedish Orphan Biovitrum AB ahead of the Annual General Meeting in 2023
AQ
11/18Vaccines and drugs in the pipeline for RSV
RE
11/18Swedish Orphan Biovitrum Proposes New Chair for May 2023 Election
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Days
:
Hours
:
Minutes
:
Seconds
All news about SWEDISH ORPHAN BIOVITRUM AB (PUBL)
11/21Sobi - Bo Jesper Hansen proposed as new Chairman of the Board of Swedish Orphan Biovitr..
AQ
11/18Vaccines and drugs in the pipeline for RSV
RE
11/18Swedish Orphan Biovitrum Proposes New Chair for May 2023 Election
MT
11/18Bo Jesper Hansen proposed as new Chairman of the Board of Swedish Orphan Biovitrum AB (..
AQ
11/10Sobi Obtains US FDA Authorization for Kineret Use in Treatment of COVID-19-Related Pneu..
MT
11/10U.S. health regulator authorizes Sobi's COVID drug
RE
11/10U.S. Food and Drug Administration Issues Emergency Use Authorization for KINERET« (anak..
AQ
11/10Sobi North America, the North American Affiliate of Swedish Orphan Biovitrum AB Announc..
CI
11/04Sanofi, Astra win EU approval for prevention of infant RSV
RE
11/01Swedish Orphan Biovitrum AB Chairman of the Board Hakan Bjorklund will not be available..
AQ
10/31Swedish Orphan Biovitrum Chair to Step Down in 2023
MT
10/31Swedish Orphan Biovitrum to Step Down in 2023
MT
10/31Swedish Orphan Biovitrum AB (publ)'s Chairman of the Board Håkan Björklund will not be ..
AQ
10/31Swedish Orphan Biovitrum AB Announces Not Stand for Re-Election of Håkan Björklund as C..
CI
10/27Transcript : Swedish Orphan Biovitrum AB, Q3 2022 Earnings Call, Oct 27, 2022
CI
10/27Sobi to Present Data from REAL-HLH Studyáat the ACR Convergence 2022 Meeting
AQ
10/27Sobi Maintains Revenue Growth Outlook for FY22
MT
10/27Sobi publishes Q3 2022 report
AQ
10/27Swedish Orphan Biovitrum AB Reports Earnings Results for the Third Quarter and Nine Mon..
CI
09/30Sobi - New number of shares and votes in Swedish Orphan Biovitrum AB
AQ
09/30New number of shares and votes in Swedish Orphan Biovitrum AB (publ)
AQ
09/16ADC Therapeutics, Sobi Say CHMP Opinion Positive for Zynlonta for Relapsed or Refractor..
MT
09/16Swedish Orphan Biovitrum, ADC Therapeutics Win Recommendation For Lymphoma Medication
MT
09/16ADC Therapeutics and Sobi Announce ZYNLONTA« (loncastuximab tesirine) Receives Positive..
CI
09/16ADC Therapeutics, Swedish Orphan Biovitrum's Co-Developed Drug Recommended for EU Autho..
DJ
09/16EU regulator backs wider use of AstraZeneca COVID therapy
RE
08/30FDA grants priority review to efanesoctocog alfa for people with haemophilia A
AQ
08/30Sanofi and Sobi Announce US Food and Drug Administration Accept Priority Review the Bio..
CI
07/21DRI Healthcare Trust Acquires Royalty Interest in Global Sales of Pegcetacoplan For US$..
MT
07/19Biovitrum AB - The Board of Directors exercises authorisation for repurchase of shares ..
AQ
07/19Transcript : Swedish Orphan Biovitrum AB, Q2 2022 Earnings Call, Jul 19, 2022
CI
07/19Sobi Sees Revenue Growth at Higher End of Guidance on Expanded Pipeline, Market Presenc..
MT
07/19Sobi publishes Q2 2022 report
AQ
07/19Swedish Orphan Biovitrum AB Provides Revenue Guidance for the Year 2022
CI
07/19Swedish Orphan Biovitrum AB Reports Earnings Results for the Second Quarter and Six Mon..
CI
07/19Swedish Orphan Biovitrum Board Authorizes Repurchase Of All Class C Shares
MT
07/13Sanofi and Swedish Orphan Biovitrum AB Announce Pivotal Data Demonstrate Once-Weekly Ef..
CI
07/13Swedish Orphan Biovitrum's Hemophilia A Therapy Confirms Efficacy in Real-World Study
MT
07/11Sanofi, Swedish Orphan Biovitrum's Pivotal Trial of Bleeding Disorder Drug Meets Primar..
MT
07/10Sanofi-Sobi's Hemophilia A Drug Efanesoctocog Alfa Protects Against Bleeds in Late-stag..
MT
07/08Sobi Secures Exclusive Rights to ADC Therapeutics' Blood Cancer Drug
MT
07/08Sobi« Announces an Exclusive License Agreement with ADC Therapeutics SA
CI
07/08Sobi to license loncastuximab tesirine from ADC Therapeutics
AQ
07/08ADC Therapeutics Announces Exclusive License Agreement with Swedish Orphan Biovitrum AB..
CI
06/28Sobi Announces Launch of the INTO-HLH Registry, a Disease Registry for Patients with He..
AQ
06/10Apellis Pharmaceuticals, Inc. and Sobi(R) Report New Data Reinforcing the Robust Effica..
CI
06/08Sobi, Apellis Start Dosing Patients in Late-Stage Trial of Rare Kidney Disease Treatmen..
MT
06/07Sanofi and Sobi « Collaborate on the Development and Commercialization of efanesoctocog..
CI
06/07Sobi, Apellis Dose First Patient In Phase 3 Study Of Pegcetacoplan For Rare Kidney Dise..
MT
06/07Apellis Pharmaceuticals, Inc. and Sobi Announces First Patient Dosed in Phase 3 VALIANT..
CI
06/01Swedish Orphan Biovitrum, Sanofi Secure US FDA's Breakthrough Therapy Designation For H..
MT
06/01FDA grants efanesoctocog alfa Breakthrough Therapy designation for haemophilia A
AQ
05/10Bulletin from Swedish Orphan Biovitrum (Sobi«)'s Annual General Meeting (AGM)
AQ
05/10Swedish Orphan Biovitrum AB Elects Bo Jesper Hansen as New Board Member
CI
04/28Swedish Orphan Biovitrum AB Reports Earnings Results for the First Quarter Ended March ..
CI
04/28Transcript : Swedish Orphan Biovitrum AB, Q1 2022 Earnings Call, Apr 28, 2022
CI
04/28Swedish Drugmaker Sobi Confirms FY22 Revenue Outlook After Q1 Growth
MT
04/28Drugmaker Sobi books profit fall on restructuring, Russia
RE
04/28Sobi publishes Q1 2022 report
AQ
04/28Swedish Orphan Biovitrum AB Provides Earnings Guidance for the Year 2022
CI
04/20Invitation : Sobi's Q1 2022 report
AQ
04/06Swedish Orphan Biovitrum AB - Annual and Sustainability Report 2021
AQ
04/06Swedish Orphan Biovitrum AB - Notice of Annual General Meeting in Swedish Orphan Biovit..
AQ
04/05Sobi publishes 2021 Annual and Sustainability Report
AQ
04/05Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
AQ
03/29SOBI Starts Collaboration With SelectImmune Pharma Over Kineret Drug
MT
03/29SelectImmune Pharma Signs Collaboration Agreement with Swedish Orphan Biovitrum AB
CI
03/23Sobi to End Manufacturing Deal With Pfizer Early; 80 Stockholm Jobs Impacted
MT
03/23Sobi Announces Contract with Pfizer for the Manufacture of Drug Substance for ReFacto A..
CI
03/23Sobi to cease ReFacto manufacturing in the first quarter of 2024
AQ
03/18SOBI Receives Approval For Use Of Gamifant In China
MT
03/18Gamifant approved in China for the treatment of primary haemophagocytic lymphohistiocyt..
AQ
03/18Gamifant Gets Approval in China for the Treatment of Primary Haemophagocytic Lymphohist..
CI
03/09Sanofi, Swedish Orphan Biovitrum Say Efanesoctocog Alfa Prevents Bleeds During Phase 3 ..
MT
03/09Sanofi Says New Hemophilia Drug Met Primary, Secondary Endpoints in Study
DJ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on SWEDISH ORPHAN BIOVITRUM AB (PUBL)